Please use this identifier to cite or link to this item: http://hdl.handle.net/1822/57956

Full metadata record
DC FieldValueLanguage
dc.contributor.authorMagalhães, Ana Xavier Silvapor
dc.contributor.authorGonçalves, Céline S.por
dc.contributor.authorFogli, Annepor
dc.contributor.authorLourenço, Tatiana Sofia Lopespor
dc.contributor.authorPojo, Martapor
dc.contributor.authorPereira, Brunopor
dc.contributor.authorRocha, Miguelpor
dc.contributor.authorReis, R. M.por
dc.contributor.authorSousa, Nunopor
dc.contributor.authorCosta, Bruno Marquespor
dc.contributor.other[et al.]-
dc.date.accessioned2019-01-09T12:28:21Z-
dc.date.available2019-01-09T12:28:21Z-
dc.date.issued2018-
dc.identifier.urihttp://hdl.handle.net/1822/57956-
dc.description.abstractThe lncRNA HOTAIR has been implicated in several human cancers. Here, we evaluated the molecular alterations and upstream regulatory mechanisms of HOTAIR in glioma, the most common primary brain tumors, and its clinical relevance. HOTAIR gene expression, methylation, copy-number and prognostic value were investigated in human gliomas integrating data from online datasets and our cohorts. High levels of HOTAIR were associated with higher grades of glioma, particularly IDH wild-type cases. Mechanistically, HOTAIR was overexpressed in a gene dosage-independent manner, while DNA methylation levels of particular CpGs in HOTAIR locus were associated with HOTAIR expression levels in GBM clinical specimens and cell lines. Concordantly, the demethylating agent 5-Aza-2'-deoxycytidine affected HOTAIR transcriptional levels in a cell line-dependent manner. Importantly, HOTAIR was frequently co-expressed with HOXA9 in high-grade gliomas from TCGA, Oncomine, and our Portuguese and French datasets. Integrated in silico analyses, chromatin immunoprecipitation, and qPCR data showed that HOXA9 binds directly to the promoter of HOTAIR. Clinically, GBM patients with high HOTAIR expression had a significantly reduced overall survival, independently of other prognostic variables. In summary, this work reveals HOXA9 as a novel direct regulator of HOTAIR, and establishes HOTAIR as an independent prognostic marker, providing new therapeutic opportunities to treat this highly aggressive cancer.por
dc.description.sponsorshipFundação Para a Ciência e Tecnologia (PTDC/ SAU-GMG/113795/2009; SFRH/BPD/33612/2009 and IF/00601/2012 to B.M.C.; SFRH/BD/88220/2012 to A.X.M.; SFRH/BD/92786/2013 to C.S.G; SFRH/BD/81042/2011 to M.P.; and SFRH/BD/51996/2012 to T.L.), Project cofinanced by Programa Operacional Regional do Norte (ON.2 – O Novo Norte), Quadro de Referência Estratégico Nacional (QREN), Fundo Europeu de Desenvolvimento Regional (FEDER); Fundação Calouste Gulbenkian (B.M.C.); and Liga Portuguesa Contra o Cancro, Portugal (B.M.C.). This article has been developed under the scope of the projects NORTE-01-0246-FEDER-000012, NORTE-01-0145-FEDER-000023 and NORTE-01-0145- FEDER-000013, supported by the Northern Portugal Regional Operational Programme (NORTE 2020), under the Portugal 2020 Partnership Agreement, through the European Regional Development Fund (FEDER). This work has been funded by FEDER funds, through the Competitiveness Factors Operational Programme (COMPETE), and by National funds, through the Foundation for Science and Technology (FCT), under the scope of the project POCI01-0145-FEDER-007038. C.J. acknowledges NHS funding to the Biomedical Research Centre. P.A. acknowledges the Plan Cancer-INSERM (CS14085CS‘Gliobiv’, PA), the Cancéropole CLARA (Oncostarter «Gliohoxas»; PA), Fonds de dotation Patrick Brou de Lauriére (PA).por
dc.language.isoengpor
dc.publisherImpact Journalspor
dc.relationinfo:eu-repo/grantAgreement/FCT/5876-PPCDTI/113795/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBPD%2F33612%2F2009/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBD%2F88220%2F2012/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBD%2F81042%2F2011/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBD%2F51996%2F2012/PTpor
dc.rightsopenAccesspor
dc.subjectHOTAIRpor
dc.subjectGlioblastomapor
dc.subjectGliomapor
dc.subjectPrognosispor
dc.subjectHOXA9por
dc.titleThe long non-coding RNA HOTAIR is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant gliomapor
dc.typearticlepor
dc.peerreviewedyespor
degois.publication.firstPage15740por
degois.publication.lastPage15756por
degois.publication.issue21por
degois.publication.volume9por
dc.identifier.essn1949-2553-
dc.identifier.doi10.18632/oncotarget.24597por
dc.description.publicationversioninfo:eu-repo/semantics/publishedVersionpor
sdum.journalOncotargetpor
Appears in Collections:ICVS - Artigos em Revistas Internacionais com Referee

Files in This Item:
File Description SizeFormat 
XAVIER~1.PDF3,01 MBAdobe PDFView/Open

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu Currículo DeGóis